Image Gallery: Purpuric fixed drug eruption from ornidazole showing leukocytoclastic vasculitis

Multifocal fixed drug eruption due to ornidazole

Case report A 40-year old woman applied to the Immunology and Allergy clinic with pruritic erythematous lesions over the lateral sides of both arms and right hip within 30 minutes after the ingestion of ornizadole 500 mg tablet. She reported that five recurrent reactions emerged with the same drug on the same locations previously, and their severity was increased consecutively. She was prescrib...

Fixed Drug Eruption Due to Ornidazole - A Case Report

Fixed Drug Eruption (FDE) is classified as cutaneous drug reaction which recurs in the same locations upon systemic administration of the same drug. Vesicles and bullae may sometimes be found, and in some cases even these are confused with Stevens Johnson Syndrome (SJS) or Toxic Epidermal Necrolysis (TEN). A male patient, 62 years old, developed FDE with the use of ornidazole. On physical exami...

Purpuric skin eruption in an illicit drug user: Levamisole-induced vasculitis.

© 2017 Kristen Whitworth. Cavalieri. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License. The first case connecting vasculitis to levamisole adulterated cocaine was published in 2010. Since that time, there have been numerous case reports of complications arising from levamisole contaminated cocaine. A case report in 2011 suggested the use o...

Mucosal fixed drug eruption.

Dermatologic Diagnosis: Leukocytoclastic Vasculitis.

Leukocytoclastic vasculitis (LCV), also termed hypersensitivity vasculitis, is a small-vessel vasculitis. The skin is the organ most commonly involved in LCV. Typical presentation is a painful, burning rash predominantly in the lower extremities. The most common skin manifestation is palpable purpura. Other skin manifestations include maculopapular rash, bullae, papules, plaques, nodules, ulcer...